GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
10.80
+0.53 (5.16%)
At close: May 8, 2025, 4:00 PM
10.66
-0.14 (-1.30%)
Pre-market: May 9, 2025, 4:59 AM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $669.90 million as of May 9, 2025. Its market cap has increased by 9.86% in one year.
Market Cap
669.90M
Enterprise Value
355.22M
1-Year Change
9.86%
Ranking
Category
Stock Price
$10.80
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $669.90M, a decrease of -17.13%. That is a compound annual growth rate of -4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 637.03M | 74.91% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |